We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. We were originally founded as a Delaware corporation on May 31, 2019 under the name Catalys SC1, Inc. On May 29, 2020, we changed our name to Mineralys Therapeutics, Inc. Our principal executive offices are located at 150 N. Radnor Chester Road, Suite F200, Radnor, PA.
Please sign in first
4.3 Thousand total shares from 1 transactions
none
15.1 Thousand total shares from 2 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
CONGLETON JON CHIEF EXECUTIVE OFFICER |
|
1,049,068 | 2023-11-22 | 6 |
|
RODMAN DAVID MALCOM CHIEF MEDICAL OFFICER |
|
15,051 | 2023-11-13 | 5 |
|
0 | 2023-09-13 | 2 | |
|
0 | 2023-09-13 | 2 | |
|
0 | 2023-07-12 | 4 | |
|
0 | 2023-07-12 | 2 | |
|
0 | 2023-04-27 | 2 | |
|
LEVY ADAM SCOTT CFO AND SECRETARY |
|
350,811 | 2023-03-17 | 3 |
|
3,218,106 | 2023-02-14 | 1 | |
|
4,519,361 | 2023-02-14 | 2 | |
|
3,178,476 | 2023-02-14 | 2 | |
|
0 | 2023-02-09 | 1 | |
|
0 | 2023-02-09 | 1 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-27 16:01:13 -0500 | 2023-11-22 | P | 4,250 | $5.97 | a | 1,049,068 | direct | |||||||||
| 2023-11-14 18:18:43 -0500 | 2023-11-13 | M | 5,017 | $0.54 | a | 15,051 | direct | -1.0324 | -12.0944 | 0.7375 | 3 | -12.0944 | 6 | |||
| 2023-11-14 18:18:43 -0500 | 2023-11-13 | M | 5,017 | d | 70,242 | direct | ||||||||||
| 2023-11-07 17:15:39 -0500 | 2023-11-03 | M | 10,034 | $0.54 | a | 10,034 | direct | -9.3137 | -16.9118 | 0.0 | 1 | -22.0588 | 4 | |||
| 2023-11-07 17:15:39 -0500 | 2023-11-03 | M | 10,034 | d | 75,259 | direct |
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 22:15:04 UTC | 4.0905 | 1.2295 | 90000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 21:45:04 UTC | 4.0905 | 1.2295 | 90000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 21:15:03 UTC | 4.0905 | 1.2295 | 90000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 20:45:04 UTC | 4.0905 | 1.2295 | 90000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 20:15:05 UTC | 4.0905 | 1.2295 | 90000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 19:45:04 UTC | 4.0905 | 1.2295 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 19:15:04 UTC | 4.0905 | 1.2295 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 18:45:05 UTC | 4.0905 | 1.2295 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 18:15:03 UTC | 4.0905 | 1.2295 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 17:45:04 UTC | 4.0762 | 1.2438 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 17:15:03 UTC | 4.0762 | 1.2438 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 16:45:04 UTC | 4.0762 | 1.2438 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 16:15:03 UTC | 4.0762 | 1.2438 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 15:45:04 UTC | 4.0762 | 1.2438 | 85000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 15:15:03 UTC | 4.0762 | 1.2438 | 100000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 14:45:03 UTC | 4.0191 | 1.3009 | 100000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 14:15:04 UTC | 4.0191 | 1.3009 | 100000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 13:45:04 UTC | 3.9919 | 1.3281 | 100000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 13:15:04 UTC | 3.9919 | 1.3281 | 100000 |
| MINERALYS THERAPEUTICS INC MLYS | 2023-11-27 12:45:04 UTC | 3.9919 | 1.3281 | 100000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
